Results From a Multi-Center Survey Among Physicians and Patients on the Acceptance of New Treatment Strategy With Third Generation of EGFR-TKI Plus Bispecific Antibody for Advanced EGFR-Mutant NSCLC
Results From a Multi-Center Survey Among Physicians and Patients on the Acceptance of New Treatment Strategy With Third Generation of EGFR-TKI Plus Bispecific Antibody for Advanced EGFR-Mutant NSCLC. // JTO Clinical and Research Reports. – URL: https://www.sciencedirect.com/science/article/pii/S266636432600127X?dgcid=rss_sd_all
Results From a Multi-Center Survey Among Physicians and Patients on the Acceptance of New Treatment Strategy With Third Generation of EGFR-TKI Plus Bispecific Antibody for Advanced EGFR-Mutant NSCLC. JTO Clinical and Research Reports. https://www.sciencedirect.com/science/article/pii/S266636432600127X?dgcid=rss_sd_all
“Results From a Multi-Center Survey Among Physicians and Patients on the Acceptance of New Treatment Strategy With Third Generation of EGFR-TKI Plus Bispecific Antibody for Advanced EGFR-Mutant NSCLC.” JTO Clinical and Research Reports.
@article{article98392,
title = {Results From a Multi-Center Survey Among Physicians and Patients on the Acceptance of New Treatment Strategy With Third Generation of EGFR-TKI Plus Bispecific Antibody for Advanced EGFR-Mutant NSCLC},
journal = {JTO Clinical and Research Reports},
url = {https://www.sciencedirect.com/science/article/pii/S266636432600127X?dgcid=rss_sd_all}
}